ULTRASOUND-GUIDED SALIVARY GLAND BOTULINUM TOXIN FOR CHRONIC SIALORRHEA IN OTOLARYNGOLOGY: PROCEDURAL TECHNOLOGY, SERVICE DELIVERY, AND PUBLIC HEALTH OUTCOMES
DOI:
https://doi.org/10.31435/ijitss.1(49).2026.6057Keywords:
Sialorrhea, Botulinum Toxin, Ultrasound Guidance, Otolaryngology, Health Technology, Public HealthAbstract
Chronic sialorrhea has consequences that extend far beyond visible drooling. In otolaryngology practice it can affect airway protection, skin integrity, communication, feeding routines, social participation, school or work functioning, and unpaid caregiver time. This review synthesizes PubMed-indexed evidence on salivary gland botulinum toxin with particular attention to how imaging support, care setting, and service organization shape clinical and public-health outcomes. PubMed was used as the core database for a structured narrative search completed on March 12, 2026, and evidence was synthesized thematically, prioritizing randomized trials, systematic reviews, consensus documents, and larger cohort studies. Across adult and pediatric populations, botulinum toxin consistently reduces drooling severity in appropriately selected patients, while ultrasound guidance improves localization confidence and supports more reproducible, teachable protocols. The major unresolved questions concern optimal gland combinations, formulation-specific dose strategies, longer-term respiratory outcomes, comparative costs across settings, and equitable access for medically underserved populations. Current evidence supports botulinum toxin as a minimally invasive component of stepwise drooling management when paired with structured swallowing assessment, caregiver-centered outcomes, and implementation models that reduce avoidable anesthesia exposure and travel burden.
References
Bekkers, S., van Ulsen, K. J., Adang, E. M. M., Scheffer, A. R. T., & van den Hoogen, F. J. A. (2020). Cost-effectiveness of botulinum neurotoxin A versus surgery for drooling: A randomized clinical trial. Developmental Medicine & Child Neurology, 62(11), 1302–1308. https://doi.org/10.1111/dmcn.14636
Berweck, S., Bonikowski, M., Kim, H., Althaus, M., Flatau-Baqué, B., Mueller, D., & Banach, M. D. (2021). Placebo-controlled clinical trial of incobotulinumtoxinA for sialorrhea in children: SIPEXI. Neurology, 97(14), e1425–e1436. https://doi.org/10.1212/WNL.0000000000012573
Daniel, S. J., Fayoux, P., Bateman, N., Boudewyns, A., Brigger, M., Chan, C. Y., Chan, K., Cheng, A., Conley, S., Kubba, H., Lambert, E. M., Muntz, H., Nuss, R., Russell, J., Rutter, M., Schwarz, Y., Spratley, J., Thevasagayam, R., Thompson, D., … Wyatt, M. (2023). Comprehensive management of anterior drooling: An International Pediatric Otolaryngology Group (IPOG) consensus statement. International Journal of Pediatric Otorhinolaryngology, 168, 111500. https://doi.org/10.1016/j.ijporl.2023.111500
Fan, T., Frederick, R., Abualsoud, A., Sheyn, A., McLevy-Bazzanella, J., Thompson, J., Akkus, C., & Wood, J. (2022). Treatment of sialorrhea with botulinum toxin injections in pediatric patients less than three years of age. International Journal of Pediatric Otorhinolaryngology, 158, 111185. https://doi.org/10.1016/j.ijporl.2022.111185
Faria, J., Harb, J., Hilton, A., Yacobucci, D., & Pizzuto, M. (2015). Salivary botulinum toxin injection may reduce aspiration pneumonia in neurologically impaired children. International Journal of Pediatric Otorhinolaryngology, 79(12), 2124–2128. https://doi.org/10.1016/j.ijporl.2015.09.029
Hockstein, N. G., Samadi, D. S., Gendron, K., & Handler, S. D. (2004). Sialorrhea: A management challenge. American Family Physician, 69(11), 2628–2634. https://www.aafp.org/pubs/afp/issues/2004/0601/p2628.html
Jost, W. H., Friedman, A., Michel, O., Oehlwein, C., Sławek, J., Bogucki, A., Ochudlo, S., Banach, M., Pagan, F., Flatau-Baqué, B., Csikós, J., Cairney, C. J., & Blitzer, A. (2019). SIAXI: Placebo-controlled, randomized, double-blind study of incobotulinumtoxinA for sialorrhea. Neurology, 92(17), e1982–e1991. https://doi.org/10.1212/WNL.0000000000007368
Jost, W. H., Friedman, A., Michel, O., Oehlwein, C., Sławek, J., Bogucki, A., Ochudlo, S., Banach, M., Pagan, F., Flatau-Baqué, B., Dorsch, U., Csikós, J., & Blitzer, A. (2020). Long-term incobotulinumtoxinA treatment for chronic sialorrhea: Efficacy and safety over 64 weeks. Parkinsonism & Related Disorders, 70, 23–30. https://doi.org/10.1016/j.parkreldis.2019.11.024
Jost, W. H., Bäumer, T., Bevot, A., Birkmann, U., Buhmann, C., Grosheva, M., Guntinas-Lichius, O., Laskawi, R., Paus, S., Pflug, C., Schroeder, A. S., Spittau, B., Steffen, A., Wilken, B., Winterholler, M., & Berweck, S. (2023). Botulinum neurotoxin type A in the interdisciplinary treatment of sialorrhea in adults and children—update and practice recommendations. Frontiers in Neurology, 14, 1275807. https://doi.org/10.3389/fneur.2023.1275807
Lindeborg, M. M., Civantos, A. M., Florentine, M., Meyer, A. K., & Rosbe, K. W. (2025). Botox injections with and without general anesthesia for pediatric sialorrhea: A cost, efficacy, and safety analysis. International Journal of Pediatric Otorhinolaryngology, 190, 112270. https://doi.org/10.1016/j.ijporl.2025.112270
Loens, S., Brüggemann, N., Steffen, A., & Bäumer, T. (2020). Localization of salivary glands for botulinum toxin treatment: Ultrasound versus landmark guidance. Movement Disorders Clinical Practice, 7(2), 194–198. https://doi.org/10.1002/mdc3.12881
Lungren, M. P., Halula, S., Coyne, S., Sidell, D., Racadio, J. M., & Patel, M. N. (2016). Ultrasound-guided botulinum toxin type A salivary gland injection in children for refractory sialorrhea: 10-year experience at a large tertiary children’s hospital. Pediatric Neurology, 54, 70–75. https://doi.org/10.1016/j.pediatrneurol.2015.09.014
Orriëns, L. B., de Groot, S. A. F., van der Burg, J. J. W., van den Hoogen, F. J. A., van Hulst, K., & Erasmus, C. E. (2024). Interdisciplinary assessment and treatment of paediatric drooling: Two decades of experience by the Nijmegen saliva control team reflected in a stepwise algorithm. European Journal of Pediatrics, 183(9), 3979–3985. https://doi.org/10.1007/s00431-024-05658-5
Reid, S. M., Johnson, H. M., & Reddihough, D. S. (2010). The Drooling Impact Scale: A measure of the impact of drooling in children with developmental disabilities. Developmental Medicine & Child Neurology, 52(2), e23–e28. https://doi.org/10.1111/j.1469-8749.2009.03519.x
Sforza, E., Onesimo, R., Leoni, C., Giorgio, V., Proli, F., Notaro, F., Kuczynska, E. M., Cerchiari, A., Selicorni, A., Rigante, D., & Zampino, G. (2022). Drooling outcome measures in paediatric disability: A systematic review. European Journal of Pediatrics, 181(7), 2575–2592. https://doi.org/10.1007/s00431-022-04460-5
Yu, Y.-C., Chung, C.-C., Tu, Y.-K., Hong, C.-T., Chen, K.-H., Tam, K.-W., & Kuan, Y.-C. (2022). Efficacy and safety of botulinum toxin for treating sialorrhea: A systematic review and meta-analysis. European Journal of Neurology, 29(1), 69–80. https://doi.org/10.1111/ene.15083
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Daria Danielczyk, Michał Babicz, Kamil Chudzicki, Wiktor Czyżewski, Katarzyna Rosa, Agata Słoma, Anna Szot, Dominik Szydełko, Martyna Szymczyk, Paweł Żurek
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
How to Cite
